AIG
RPRX icon

American International Group’s Royalty Pharma RPRX Stock Holding History

American International Group’s Portfolio RPRX Stock Details RPRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-3,059
Closed -$92.9K – 2181
2024
Q1 		$92.9K Buy
3,059
+5
+0.2% +$147 ﹤0.01% 2562
2023
Q4 		$85.8K Sell
3,054
-78
-2% -$2.14K ﹤0.01% 2642
2023
Q3 		$85K Sell
3,132
-177
-5% -$5.26K ﹤0.01% 2596
2023
Q2 		$102K Sell
3,309
-434
-12% -$14.7K ﹤0.01% 2566
2023
Q1 		$135K Sell
3,743
-83
-2% -$3.08K ﹤0.01% 2320
2022
Q4 		$151K Sell
3,826
-25
-0.6% -$1.04K ﹤0.01% 2299
2022
Q3 		$155K Buy
3,851
+10
+0.3% +$427 ﹤0.01% 2306
2022
Q2 		$161K Sell
3,841
-1,203
-24% -$49.3K ﹤0.01% 2329
2022
Q1 		$197K Sell
5,044
-36
-0.7% -$1.41K ﹤0.01% 2249
2021
Q4 		$202K Sell
5,080
-179
-3% -$6.95K ﹤0.01% 2367
2021
Q3 		$190K Sell
5,259
-468
-8% -$18.2K ﹤0.01% 2460
2021
Q2 		$235K Buy
5,727
+457
+9% +$19.4K ﹤0.01% 2404
2021
Q1 		$230K Buy
5,270
+3,295
+167% +$156K ﹤0.01% 2295
2020
Q4 		$99K Buy
1,975
+388
+24% +$16.5K ﹤0.01% 2666
2020
Q3 		$67K Buy
+1,587
New +$68.1K ﹤0.01% 2748

Other funds holding RPRX

Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

American International Group's RPRX Position: Q2 2024 in Review

American International Group sold out of Royalty Pharma (RPRX) in Q2 2024, closing a stake of 3,059 shares — an estimated $92.9K sold.

American International Group first reported a position in RPRX in Q3 2020 and held it in 15 quarters. The position peaked at $235K in Q2 2021. 378 funds tracked by Wall St. Rank hold RPRX as of Q2 2024.

  • American International Group reported no remaining Royalty Pharma position as of Q2 2024 after selling out during the quarter.
  • American International Group sold 3,059 Royalty Pharma shares in Q2 2024, an estimated $92.9K.
  • American International Group first reported a position in Royalty Pharma in Q3 2020 and held it in 15 quarters.
  • American International Group's Royalty Pharma position peaked at $235K in Q2 2021.
  • 378 funds tracked by Wall St. Rank held Royalty Pharma as of Q2 2024.

Based on American International Group's 13F filing for Q2 2024, filed 13 Aug 2024.